GE HealthCare Technologies Inc. (GEHC)

Market Closed

16 Oct, 08:00 PM

NASDAQ (NGS)

69. 57

-0.78

-1.1087%

31.78B Market Cap

28.36 P/E Ratio

0.09% Div Yield

3.12M Volume

4.3 Eps

$ 70.35

Previous Close

Investors:

+338

Analysts:

Add Transaction

Day Range

69.45 71.32

Year Range

58.75 89.77

Want to track GEHC and more in your Portfolio? 🎯

Get Started For Free

GE HealthCare Gains FDA Clearance for AI Radiation Planning Software

GEHC wins FDA clearance for AI-powered radiation planning software, adding new clinical models and a pathway for faster future updates.

Zacks | 4 months ago

GE HealthCare Technologies Inc. (GEHC) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Seekingalpha | 4 months ago

GE HealthCare Technologies: Doing Some Bottom Fishing

Seekingalpha | 4 months ago

GE HealthCare and UW Medicine Radiology Expand CT, MI Research Tie

GEHC teams with UW Medicine Radiology to advance CT and molecular imaging, aiming to automate workflows and speed next-gen imaging to clinics.

Zacks | 4 months ago

GE HealthCare Technologies Sticks to Growth Story After Inflation-Driven Guidance Cut

GE HealthCare Technologies NASDAQ: GEHC executives said the company remains confident in its long-term growth prospects despite a disappointing first quarter that led to a reduction in full-year guidance, citing inflationary cost pressures as the primary near-term challenge.

Marketbeat | 5 months ago

GE HealthCare Technologies Inc. (GEHC) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Seekingalpha | 5 months ago

GE HealthCare Expands SIGNA MR Portfolio With AI-Powered Tools

GEHC unveils AI-powered MRI innovations at ISMRM 2026, expanding imaging speed, quality and research collaboration tools.

Zacks | 5 months ago

GEHC Launches MIM ComboTherapy for GYN Cancer Radiation Planning

GE HealthCare launches MIM ComboTherapy to improve radiation planning for gynecologic cancers with advanced dose visualization.

Zacks | 5 months ago

GE HealthCare Just Crashed 13% on a Guidance Cut. Here's the Case for Buying the Dip

GE HealthCare (NASDAQ: GEHC | GEHC Price Prediction) currently trades at $59.49, well below the Wall Street consensus price target of $89.74.

247wallst | 5 months ago

GE HealthCare Q1 2026: Inflation And Execution Risks Weigh On Outlook

GE HealthCare Technologies is rated a hold following 1Q26, reflecting resilient demand but significant near-term margin pressure. GEHC maintains a robust $21.8B backlog and credible innovation pipeline, supporting mid-single-digit revenue growth, yet faces execution risk from lagged pricing actions. Profitability was hit by $250M in inflation headwinds, tariffs, and Patient Care Solutions weakness, leading to a downward revision in adjusted EPS guidance to $4.80–$5.00.

Seekingalpha | 5 months ago

GE HealthCare: Soft Execution More Than Priced Accordingly

GE HealthCare shares have fallen to $60 after a soft Q1 and guidance cut, now trading at the low end of their post-spin range. Q1 organic growth was 2.9%, below full-year targets, and EBIT margin guidance was trimmed, but valuation multiples have compressed to 12–13x earnings. Despite headwinds—tariffs, supplier issues, and rising costs—GE HealthCare maintains 3–4% organic growth guidance and is integrating the Intelerad acquisition for incremental EBITDA.

Seekingalpha | 5 months ago

GE HealthCare Technologies Inc. (GEHC) Q1 2026 Earnings Call Transcript

Seekingalpha | 5 months ago

Blog Affiliate Program Dividend Tracker About Terms Privacy Help Contact Us